A Study of Remternetug (LY3372993) in Healthy Chinese Participants

NCT07346495 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3372993
DRUG: Placebo

Sponsor

Eli Lilly and Company